MedTrace Logo

Next Generation Sequencing in Intrahepatic Cholangiocarcinoma

NCT02184871 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2014-07-09

No results posted yet for this study

Summary

The aim of the present study is to perform a comprehensive molecular characterization of intrahepatic cholangiocarcinoma (ICC) in patients exposed to well-known or putative risk factors (such as asbestos) for this malignancy, in order to identify possible "molecular signatures" associated to such different risk factors.

Conditions

  • Intrahepatic Cholangiocarcinoma

Interventions

OTHER

exposure to different risk factors and molecular assessment

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Principal Investigators

  • Giovanni Brandi · University of Bologna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-05-31
Completion
2017-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02184871 on ClinicalTrials.gov